EDITAS MEDICINE INC.

Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual Meeting

10 May 2024 06:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

08 May 2024 09:49:21 By NetDania Notify

Editas Medicine Announces First Quarter 2024 Results and Business Updates

08 May 2024 07:00:01 By Nasdaq GlobeNewswire

Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events

02 May 2024 07:00:00 By Nasdaq GlobeNewswire

Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration

01 May 2024 08:00:01 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

25 Apr 2024 09:45:02 By NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

24 Apr 2024 15:42:20 By NetDania Notify

Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting

22 Apr 2024 16:31:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

19 Apr 2024 09:45:22 By NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

18 Apr 2024 09:45:09 By NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

17 Apr 2024 09:45:46 By NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

16 Apr 2024 09:45:13 By NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

15 Apr 2024 10:47:30 By NetDania Notify

Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates

28 Feb 2024 07:00:01 By Nasdaq GlobeNewswire

Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor Events

21 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Editas Medicine to Participate in Upcoming Investor Conferences

31 Jan 2024 09:00:00 By Nasdaq GlobeNewswire

Editas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities at the J.P. Morgan Healthcare Conference

08 Jan 2024 08:15:00 By Nasdaq GlobeNewswire

Editas Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference

03 Jan 2024 07:00:00 By Nasdaq GlobeNewswire

Editas Medicine and Vertex Pharmaceuticals Enter into Non-exclusive License Agreement for Cas9

13 Dec 2023 09:00:00 By Nasdaq GlobeNewswire

Editas Medicine Announces New EDIT-301 Safety and Efficacy Data in 17 Patients, Presented Today at the American Society of Hematology (ASH) Annual Meeting and in a Company-sponsored Webinar

11 Dec 2023 12:00:00 By Nasdaq GlobeNewswire